Last reviewed · How we verify
NCT02417792: PIB
The Association Between Psoriasis and Intestinal Bacterial Population
trial in Psoriasis in 46 participants. Completed in 18 February 2019.
6 January 2019
Quick facts
| Lead sponsor | Assuta Hospital Systems |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 14 May 2015 |
| Primary completion | 6 January 2019 |
| Estimated completion | 18 February 2019 |
Conditions studied
- Psoriasis — all drugs for Psoriasis →
Sponsor
Assuta Hospital Systems
Who can join
Adults 18 to 80, any sex, with Psoriasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
At least 20 psoriasis patients will be compared to at least 20 participants without psoriasis Bacterial genomic DNA will be extracted from stool samples of participants. The intestinal bacterial populations will be compared in order to examine whether there are differences between the groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02417792
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psoriasis
Currently open trials in the same condition.
- NCT07471048 — A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoria · NA · recruiting
- NCT07449234 — A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis · recruiting
- NCT07234838 — Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO) · recruiting
- NCT07194200 — Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial · Phase 2 · recruiting
- NCT07250997 — PALLAS Laser for Skin Diseases · NA · recruiting
Other Assuta Hospital Systems trials
Trials by the same sponsor.
- NCT03505268 — The Impact of Telehealthcare Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes · NA · unknown
- NCT03362138 — Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions · unknown
- NCT03046472 — Physical Therapy Treatment Once a Month Versus Once a Week for Posture Improvement in Children and Adolescents · NA · completed
- NCT02955277 — The Effectiveness of TECH: Tablet Enhancement of Cognition and Health · NA · completed
- NCT02824796 — Group Training for Parents Whose Children Suffer From ADHD and Comorbidity Using a Behavioral-Dynamic Approach · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02417792 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assuta Hospital Systems
- Last refreshed: 25 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02417792.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing